Recent developments in the European Union (EU), such as the latest opinions of the Scientific Committee on Consumer Safety (SCCS), highlight the evolution of cosmetics safety scrutiny. This increased focus on consumer health and safety, particularly regarding endocrine disruptors, is not shared by the US cosmetics market.